GILD
Gilead Sciences, Inc.
Stock
$149.05−2.23 (−1.47%)Close Sep 30, 2026
| Stock-based compensation (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $909M | +4.2% | 6.8% | 8.9% |
| Stock-based compensation (TTM) | $909M |
|---|---|
| YoY | +4.2% |
| 5-year CAGR | 6.8% |
| 10-year CAGR | 8.9% |
Stock-based compensation
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $894M | +7.1% |
| 2024 | $835M | +9.0% |
| 2023 | $766M | +20.3% |
| 2022 | $637M | +0.3% |
| 2021 | $635M | −1.2% |
| 2020 | $643M | +1.1% |
| 2019 | $636M | −24.7% |
| 2018 | $845M | +32.4% |
| 2017 | $638M | +67.9% |
| 2016 | $380M | −0.5% |
| 2015 | $382M | +6.1% |
| 2014 | $360M | +42.9% |
| 2013 | $252M | +20.6% |
| 2012 | $209M | +8.6% |
| 2011 | $192M | −3.8% |
| 2010 | $200M | +10.7% |
| 2009 | $181M | +17.8% |
| 2008 | $153M | −16.9% |
| 2007 | $185M | — |